One in Two

In the latest episode of One in Two: A Manchester Cancer Research Podcast, we speak to Professor Matt Evison, Professor of Thoracic oncology, and never-smoker ALK+ lung cancer patient, Sally Hayton about:

·      Never-smoker lung cancer symptoms, de... more

In this episode, we speak to Professor David Wedge, Professor of Cancer Genomics and Data Science, about breast cancer in Black African women, focussing on:

·      Cancer genomics and what we understand ethnicity to be in the context of genomic rese... more

In this episode, we speak to Dr Emma Woodward and patient Nick Brown, about hereditary cancer predisposition,  focusing on:

 ·      Li Fraumeni Syndrome (LFS), a rare cancer predisposing condition which gives a 70% lifetime risk of developing cancer... more

In this episode, we speak to Corinne Faivre-Finn, a Professor of Thoracic Radiation Oncology about lung cancer clinical trials, focussing on:

 ·      Radiotherapy: what it is and how it’s used to treat lung cancers

 ·      Clinical trials: what are... more

In this episode, we speak to Dr Fabio Gomes, a Consultant Medical Oncologist at The Christie NHS Foundation Trust, about lung cancer in never smokers, focusing on:

•  The commonality of lung cancer in never smokers

•  Why never smokers are susceptib... more

In this episode, we speak to Professor Caroline Dive, Professor of Cancer Pharmacology at The University of Manchester, Interim Director of the Cancer Research UK Manchester Institute and Director of the CRUK Cancer Biomarker Centre, about cancer bio... more

In this episode, we speak to Dr Colin Lindsay, Clinical Senior Lecturer at The Christie and The University of Manchester about the basic biology of lung cancer, focusing on:

•  The high incidence of lung cancer here in Manchester

•  The differences ... more

In this special episode, we speak to Dr Jen Davies-Oliveira, a researcher and PhD student at The University of Manchester and Stewart O’Callaghan, the Founder and Chief Executive of Live Through This, the UK’s only LGBTQIA+ Cancer charity. We discuss... more